RT Journal Article
SR Electronic
T1 Quantifying individual nociceptive sensitivity to optimise analgesic trials in infants
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.08.20246058
DO 10.1101/2020.12.08.20246058
A1 Maria M. Cobo
A1 Caroline Hartley
A1 Deniz Gursul
A1 Foteini Andritsou
A1 Marianne van der Vaart
A1 Gabriela Schmidt Mellado
A1 Luke Baxter
A1 Eugene P. Duff
A1 Miranda Buckle
A1 Ria Evans Fry
A1 Gabrielle Green
A1 Amy Hoskin
A1 Richard Rogers
A1 Eleri Adams
A1 Fiona Moultrie
A1 Rebeccah Slater
YR 2020
UL http://medrxiv.org/content/early/2020/12/11/2020.12.08.20246058.abstract
AB Despite the high burden of pain experienced by hospitalised infants there are few analgesics with proven efficacy. Testing analgesics in infants is experimentally and ethically challenging and minimising the number of infants required to demonstrate efficacy is essential. EEG-derived measures of noxious-evoked brain activity can be used to assess analgesic efficacy, however, as variability exists in infant’s responses to painful procedures, large sample sizes are often required. Here we present a novel experimental paradigm to account for individual differences in baseline nociceptive sensitivity which can be used to improve the design of analgesic trials in infants. The paradigm is developed and tested across four studies using clinical, experimental and simulated data (99 infants). We provide evidence of the efficacy of both gentle brushing and paracetamol, substantiating the need for randomised controlled trials of these interventions. This work provides an important step towards safe, cost-effective clinical trials of analgesics in infants.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was funded by the Wellcome Trust via a Senior Fellowship awarded to Rebeccah Slater (Grant number 207457/Z/17/Z).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was obtained from the National Research Ethics Service (reference 12/SC/0447) and informed written parental consent was obtained prior to each study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study, including data to produce figures 1, 3, 4, 5 and supplementary figures 1 to 5, are available from the corresponding author upon reasonable request. Data sharing requests should be directed to rebeccah.slater{at}paediatrics.ox.ac.uk.